The company is committed to developing generic and innovative drugs with independent innovation capabilities and international competitiveness.
Adopting a full industrial chain development model, starting from the source, it forms the entire supply process from upstream raw materials to formulation products.

 

Strategic cooperation

 

  • CMO/CDMO business for active pharmaceutical ingredients

    We undertake the settlement, contract manufacturing and customization services of conventional reactions, hydrogenation reactions, active pharmaceutical ingredients, intermediates, cosmetic raw materials and other products

  • Medical device CMO/CDMO business

    We undertake the production of pre-filled needles for Class III injection filling products, as well as the production of Class II gels/dressings, including settlement, consignment production, customization, and OEM services